953
Participants
Start Date
June 30, 2015
Primary Completion Date
July 31, 2016
Study Completion Date
November 30, 2016
Galeterone
2550 mg galeterone tablets once daily PO
Enzalutamide
160 mg enzalutamide capsules once daily PO
Prince of Wales Hospital, Randwick
Macquarie University, Sydney
St. George Private Hospital, Oncology Day Care Centre, Kogarah
North Coast Cancer Institute, Port Macquarie
Peter MacCallum Cancer Centre, East Melbourne
Box Hill Hospital, Box Hill
Cabrini Hospital, Malvern
Monash Medical Centre, East Bentleigh
Hospital General Universitario de Elche, Elche
CHU Sart Tilman, Liège
Peninsula Specialist Centre, Kippa-Ring
Princess Alexandra Hospital, Woolloongabba
ICON Cancer Care, Southport
Ashford Cancer Centre/Adelaide Cancer Centre Research, Kurralta Park
Ashford Cancer Centre/Adelaide Cancer Centre Research, Kurralta Park
"AOU S. Luigi, SCDU Oncologia Medica", Orbassano (Torino)
University of Turin, Torino
Brooklyn Urology Research Group, Brooklyn
Advanced Urology Centers of New York, Plainview
Premier Medical Group of the Hudson Valley, Poughkeepsie
Associated Medical Professionals of NY, Syracuse
Centre François Baclesse, Caen
UPMC Cancer Centers, Pittsburgh
Lancaster Urology, Lancaster
Fox Chase Cancer Center, Philadelphia
Georgetown University Medical Center, Washington D.C.
Sibley Memorial Hospital, Washington D.C.
Walter Reed National Military Medical Center, Bethesda
University of Maryland Greenenbaum Cancer Center, Baltimore
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Virginia Urology, Richmond
Urology of Virginia, Virginia Beach
University of North Carolina Lineberger Cancer Center, Chapel Hill
Hospital General Universitario Gregorio Marañón, Madrid
Carolina Urology Partners, Concord
Spanish National Cancer Research Centre, Madrid
Carolina Urology Partners, PLLC, Charlotte
Carolina Urologic Research Center, Myrtle Beach
Hospital Clinico Universitario de Navarra, Pamplona
University of Florida Health Cancer Center, Orlando
Institut Bergonié, Bordeaux
Boca Raton Community Hospital, Inc., Boca Raton
Moffitt Cancer Center, Tampa
Urology Associates Clinical Research, Nashville
Santa Chiara Hospital, Trento
Hospital Universitario Virgen del Rocio, Seville
Institut de Cancerlogie de la Loire, Saint-Priest-en-Jarez
Clinical Research Solutions, Middleburg Heights
Centre René Gauducheau, Saint-Herblain
Institut de Cancérologie de l'Ouest, Saint-Herblain
The Urology Group, Cincinnati
IVO-Oncología Médica, Valencia
Romagnolo per lo Studio e la Cura dei Tumori IRST-IRCCS - Oncologia medica, Meldola (FC)
First Urology, Jeffersonville
Unità Operativa di Oncologia Ospedale Civile degli Infe, Faenza (RA)
University of Michigan Health System, Ann Arbor
Karmanos Cancer Center, Detroit
Centre Paul Papin, Angers
Centro Oncologico c/o Presidio Ospedaliero San Donato - Arezzo, Arezzo
The University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison
Urology Cancer Center and GU Research Network, Omaha
Centre Léon Bérard, Lyon
Tulane Medical Center, New Orleans
Regional Urology, LLC, Shreveport
Clinique Victor Hugo Centre Jean Bernard, Le Mans
Urology Clinics of North Texas, Dallas
Texas Oncology/Baylor University Medical Center, Dallas
Urology San Antonio, San Antonio
University of Colorado Cancer Center Anschultz Cancer Pavilion, Aurora
The Urology Center of Colorado, Denver
Institut Sainte Catherine, Avignon
Pinnacle Oncology Hematology, Scottsdale
University Of Arizona Cancer Center, Tucson
Service de Médecine Interne Onco-Hématologie, La Roche-sur-Yon
USC Norris Comprehensive Cancer Center, Los Angeles
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
Prostate Oncology Specialists, Inc., Marina del Rey
Urology Speciality Group, Torrance
City of Hope, Duarte
San Bernardino Urological Associates, San Bernardino
Institut Gustave-Roussy, Villejuif
UC Davis Cancer Center, Sacramento
Oregon Urology Institute, Springfield
Yale University School of Medicine, New Haven
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Center, Boston
Coastal Urology Associates, Brick
Jules Bordet Institute Clinique d'Oncologie Medicale, Brussels
Universitair Ziekenhuis Gent, Ghent
Jessa Ziekenhuis, Hasselt
British Columbia Cancer, Kelowna
British Columbia Cancer, Vancouver
London Health Sciences Centre, London
Sunnybrook Research Institute, Toronto
Princess Margaret Hospital, Toronto
Centre Hospitalier De I'Universite de Montreal, Montreal
Centre Hospitalier Universitaire de Quebec, Québec
Hôpital Edouard Herriot, Lyon
Centre Antoine Lacassagne, Nice
Az. Ospedaliera San Camillo-Forlanini, Roma
Hospital Clínic i Provincial de Barcelona-Oncology, Barcelona
Instituto Catalan de Oncologia (Hospital Durans i Reynals), Barcelona
Fundación Althaia Manresa, Manresa
Unidad Cnio Ibima de Investigacion en Prostata, Málaga
Hospital Son Espases - Oncología, Palma de Mallorca
Consorci Hospitalari de Parc Taulí, Sabadell
CR-UK Institute for Cancer Studies, Birmingham
Sussex Cancer Centre, Brighton
University College of London Hospitals, London
Guy's and St. Thomas' NHS Foundation Trust, London
Southampton General Hospital, Southampton
University of Surrey Post Graduate Medical Hospital, Surrey
Royal Marsden Hospital, Surrey
The Royal Cornwall Hospital, Truro
The Beatson West of Scotland Cancer Centre, Glasgow
Velindre Hospital, Cardiff
Lead Sponsor
LTN PHARMACEUTICALS, INC.
INDUSTRY